[생명공학] Cancer cell Imaging & Treatment(영문)

  • 등록일 / 수정일
  • 페이지 / 형식
  • 자료평가
  • 구매가격
  • 2010.12.07 / 2019.12.24
  • 15페이지 / fileicon docx (MS워드 2007이상)
  • 평가한 분이 없습니다. (구매금액의 3%지급)
  • 1,400원
다운로드장바구니
Naver Naver로그인 Kakao Kakao로그인
최대 20페이지까지 미리보기 서비스를 제공합니다.
자료평가하면 구매금액의 3%지급!
이전큰이미지 다음큰이미지
목차
1. Introduction

2. Cancer Cell Targeting

2.1. Basic ideas of cancer treatment research
2.2. Drug targeting

3. Problem and things to be advanced

4. Mechanism

4.1. Linking the Domains
4.2. Functions of Domains
4.3. Stepwise Mechanism of Molecular Complex

5. Conclusion

6. Reference
본문내용
(2) Active targeting

Nanoparticle passive targeting can be enhanced by ‘active targeting’, where specific ligands (peptides, antibodies, aptamers, or small molecules) are attached to the nanoparticle surface to bind receptors/antigens overexpressed on cancer cells. Targeting increases accumulation in tumors and lessens exposure to healthy tissue, which can improve a toxic drug’'s therapeutic index and reduce adverse side effects.

According to its importance, many researches these days are trying to identify and develop specific antigens and receptors that are unique to cancer cells. The decoration of nanoparticles with tumor targeting molecules, such as hormones, growth factors etc. can increase the efficacy of a treatment. Integrin, EGFR are usually the target receptors.

Figure 3 A description of passive and active targeting. Blood vessel near tumor is not well organized, and numbers of pores are found. EPR effect is observed only at the tumor tissue. Through this effect, drugs are accumulated.


3. Problem and things to be advanced

We cover the meaning of cancer targeting, and how to target cancer. Nowadays, there are many not only drugs but also treatments for cancer treatment, but they have some problems.

1. Chemical-based Anticancer drugs
These chemical-based drugs are systemic drug. Therefore, normal cells are also regarded as cancer cells and become treated. Normal cells are attacked by chemical-drug, and then many cells are damaged. It brings out many side effects. The patient gets a lot pain when he or she receives anticancer treatments
2. Drugs Detecting Receptors on Cancer Cell’s Surface
The receptors, which is important to cancer targeting, exist not only on the cancer cell’s surface but also on the normal cell’s surface. So we have a potential to mis-treatment.

So, we focused on overcoming of these drawbacks. To overcome these side effects we considered two things.

1. Nano-sized particle
Nano-sized particle is the method for passive targeting. So our final molecule should be less than 200~300nm in order to pass the pores of abnormal vessels. These nano-sized particles can detect cancer cell because of EPR effect. So size of particles is important.
2. Integrin αvβ3
Integrin αvβ3 is the method for active targeting. Most of cancer cell have these receptor. Selection of molecules which target this receptor should be made.

For our strategy to use double targeting, we use special peptide pHLIP(pH Low Insertion Peptide). Cancer cells accumulate pyruvate due to insufficient O2 and consequent decrease of oxidative phosphorylation. So H+ pumps transport protons to extracellular fluid to maintain normal cytoplasmic pH.

Thus, Tumor acidity is a specific tumor biomarker. pHLIP is pH-dependent molecule, so it detects the concentration change of proton. If pH is lower in extracellular surface, this molecule enters into phospholipid bilayer due to transmembrane part containing uncharged Asp by
참고문헌
[1] Kumar, V., Cotran, R.S., and Robbins, S.L. (2003), Robbins Basic Pathology, PA : Saunders.
[2] Fauci, A.S. (2008), Harrison’s Principles of Internal Medicine, NY : McGraw-Hill Medical.
[3] Katzung, B.G. (2007), Basic & Clinical Pharmacology, NY : McGraw-Hill
[4] Hillery, A. M., Lloyd, A. W., and Swarbrick, J. (2001), Drug delivery and targeting for pharmacists and pharmaceutical scientists, New York : Taylor&Francis.
[5] Adiseshaiah, P. P., Hall, J. B., and McNeil, S. E. (2009), Nanomaterial standards for efficacy and toxicity assessment.
[6] Kwon G. S. (2005), Polymeric drug delivery systems, New York : Taylor&Francis.
[7] Gregoriadis, G., McCormack, B. (1998), Targeting of drugs 6: strategies for stealth therapeutic systems, New York : Plenum Press.
[8]유미경, 박진호, 전상용, “암 진단용 자기공명영상 나노조영제”, 고분자과학과 기술, 19권 2호, 한국고분자학회, 2008.
[9] Enhanced permeability and retention effect, Wikipedia(www.wikipedia.org).
[10]http://www.kostat.go.kr/nso_main/nsoMainAction.do?method=search&catgrp=nso2009&catid1=k09___0000&catid2=k09i__0000&forward=search – 사망원인통계(전국편, 2008년) : 표5
[11] Reshetnyak, Y.K., Andreev, O.A., Lehnert, U., Engelman, D.M. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc. Natl. Acad. Sci. USA. 103, 6460-6465 (2006)
[12] Crasto, C.J., Feng, J. LINKER: a program to generate linker sequences for fusion proteins. Protein Engng. 13, 309-312 (2000).
[13] Sugahara, S., Kajiki, M., Kuriyama, H., Kobayashi, T. Paclitaxel Delivery Systems: The Use of Amino Acid Linkers in the Conjugation of Paclitaxel with Carboxymethyldextran to Create Prodrugs. Biol. Pharm. Bull. 25(5), 632-641 (2002).
[14]Hunt, J.F., et. al. Spontaneous, pH-dependent membrane insertion of a transbilayer α-helix. Biochemistry-US. 36, 15177-15192 (1997)
[15] Cheng, Kenneth T.. “Cy7-Tetrameric arginine-glycine-aspartic acid peptide [Cy7-E{E[c(RGDyK)]2}2]”. MICAD. 25 May 2010.
[16] Shan, Liang. “Cy5.5-labeled pH low insertion peptide (pHLIP)”. MICAD. 5 May 2010.
[17] Segala, J.. Accurate analysis of tumor margins using a fluorescent pH low insertion peptide(pHLIP). Int. J. Mol. Sci. 10, 3478-3487 (2009).
[18] Stolik S., et. al. Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues. J. Photoch. Photobio. B. 57, 90-93 (2000).
[19] Shakley, D.C.. Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumors. BJU Int. 86, 638-643 (2000).
[20] Shim, I.K. Ehwa Woman’s University, 25 May 2010. < dream.ewha.ac.kr/~epharm/cgi-bin/spboarda/board.cgi?id=pds&action=download&gul=1228>
자료평가
    아직 평가한 내용이 없습니다.
회원 추천자료
  • Cell line 레포트
  • cell stock 가능- 약 42-46번 분열 후 노화MRC-5Finite Cell LineWI-38- 3개월 된 여자 태아의 폐에서 유래- 원래 Virus를 이용한 Vaccine 제조 생산을 목적으로 개발- 세포 노화 연구를 위한 분열수 적은 어린 세포 구하기 어려움- 노화 연구시 WI-38 대신 대용품 사용WI-38Types of Cell lineInfinite Cell LinePotential to be sub-cultured indefinitely(continuous, immortal cell line)Transformed cells(altered growth properties)Not necessary mean cancer, tumor cells, but may induce tumors in animal modelsInfinite Cell LineEB

  • 바이오산업의 현주소와 미래전망
  • Cell therapy■ Transgenic plant/Animal■ Biocatalyst Metabolic Engineering참고자료: 4.바이오테크시대3.1 Biopharmaceutcals 생산 기술▶개요 Biopharmaceutcals는 단백질제제 혹은 단순히 유전공학 제품이라고도 하며 1980년대부터 당뇨병 치료제인 인슐린, 왜소증 치료제로 사용되고 있는 성장호르몬(human growth hormone), B형 간염, C형 간염 및 여러가지 희귀암 치료제로 사용되고 있는 인터페론 알파(interferon alpha), B형 간염, C형 간염 및 여러가지 희귀암 치료제로 쓰이는 백혈구

  • Epigenetics(후성 유전학)의 최근 연구 동향
  • 생명이 얼마나 신비롭고 또 신비로운 것인지 새삼 느끼게 되어 좋았다.◉ 김한솔 : 논문을 찾고 읽고, 이해하는 과정에서 어려움을 겪기는 했지만 나름대로 새로운 지식을 터득해감에 보람 있는 시간이었다. 매우 최근의 논문들을 찾을 수 있었던 것을 보면 현재 계속해서 후성유전학에 대한 연구가 진행되어 지고 있음을 알 수 있었다. 후성 유전적 요인들은 알면 알수록 더 복잡하고 완벽히 밝힐 수 없는 분야인 것 같다. 하지만 끊임없는 연구의 결과

  • 울산과학기술원(UNIST,유니스트) 대학원 (영문) 자기소개서
  • cancer cells. Through meticulous experimentation and data analysis, I uncovered novel interactions between specific microRNAs and their target genes, shedding light on potential therapeutic targets for cancer treatment. This experience not only reinforced my commitment to scientific inquiry but also ignited my enthusiasm for deciphering the molecular mechanisms underlying complex diseases.Furthermore, I am captivated by the interdisciplinary nature of life sciences and the potential for cross-pollination between different subfields. I am eager to collaborate with experts from diverse backgro

  • [의약학] 논문요약-Inhibitory Effects of Fucoidan in 3T3-L1 Adipocyte Differentiation(영문)
  • cells. (by MTT)Lipid accumulation was reduced at 200 μg/ml. (by Morphology)Fucoidan can reduce adipogenesis. (by Oil red O staining)Decreasing expression of aP2, ACC, and PPAR genes. (by RT-PCR)Fuicoidan inhibits differentiation of 3T3-L1 preadipocyte into adipocyteiNOS pathwayFucoidanCancer : apoptosis + veseelImmune : macrophage + lymphocyteOther functionPreadipocyte → AdipocyteFucoidan & AdipocyteaP2 ↓ACC ↓PPARγ ↓DifferentitationOther ProductsOther Products2010. 11. 19. (Fri)Th

오늘 본 자료 더보기
  • 오늘 본 자료가 없습니다.
  • 저작권 관련 사항 정보 및 게시물 내용의 진실성에 대하여 레포트샵은 보증하지 아니하며, 해당 정보 및 게시물의 저작권과 기타 법적 책임은 자료 등록자에게 있습니다. 위 정보 및 게시물 내용의 불법적 이용, 무단 전재·배포는 금지됩니다. 저작권침해, 명예훼손 등 분쟁요소 발견시 고객센터에 신고해 주시기 바랍니다.
    사업자등록번호 220-06-55095 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.02-539-9392
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1806호 이메일 help@reportshop.co.kr
    copyright (c) 2003 reoprtshop. steel All reserved.